Prepared for
Light
Frequency Research Compounds
Precision sub-cutaneous
preparations. Research grade.
Each compound is aseptically reconstituted, sterile filtered at 0.2 μm PVDF, and gravimetrically filled into pen vials. Tap any card for full research detail and mechanism.
◆ All compounds are for research use only · Not for human therapeutic use · Researcher agreement required
◆ Research & Education Videos
Short — Research Insight
Frequency Research Compounds
How to Prime a Pen
Pen Priming · Getting Started
Best Peptide to Lose Fat — MOTS-c vs GLP-1
MOTS-c · GLP3-Plus
NAD+ vs Methylene Blue — Which is Best?
NAD+
Doctor Reveals 3 Mitochondrial Fixes
Mitochondrial Health
GLP3-Plus — Metabolic Signalling
GLP3-Plus
GLP3-Plus — Full Explainer
GLP3-Plus
Short — Research Insight
Frequency Research Compounds
Short — Research Insight
Frequency Research Compounds
◆ Frequently Asked Questions
◆ Getting Started

All compounds are supplied for personal research purposes only and are not approved for human therapeutic use by any regulatory authority. By submitting an enquiry you confirm your understanding of this research-only status.

The reusable pen has a 60-click graduated barrel. 30 clicks = 0.25ml — the standard dose for most compounds. Each click is precise and consistent. Prime the pen before first use by expelling a small amount before the first injection.

Note: SS-31 uses a 2.25ml fill rather than 3.03ml, giving 9 doses per vial instead of 12. All other compounds give 12 doses per vial at 30 clicks.

Insert the pen needle through the vial septum. Pull the plunger back slowly to the desired click count. Withdraw the needle, tap out any air bubbles, and expel a small amount to confirm flow before injecting. Store the loaded pen tip-down in the refrigerator if not using immediately.

30 clicks = 0.25ml · 3.03ml fill · 0.9% BAC water

CompoundVialConcentrationmg / 30 clicksDoses/vial
MOTS-c20mg6.60mg/ml1.65mg12
BPC-15710mg3.30mg/ml0.83mg12
TB-50010mg3.30mg/ml0.83mg12
SS-3110mg4.44mg/ml1.11mg9 *
GHK-Cu50mg16.50mg/ml4.13mg12
Ipamorelin2mg0.66mg/ml0.17mg (165mcg)12
* SS-31 uses a 2.25ml fill — 9 doses per vial at 30 clicks. All others use 3.03ml fill.
◆ GLP3-Plus Protocol

GLP3-Plus (Retatrutide / LY3437943) simultaneously activates GLP-1, GIP, and glucagon receptors — a triple agonist. Phase 2 trial data: 22.8% mean body weight loss at 8mg/week over 48 weeks.

The protocol runs across three vials over approximately 10 weeks to reach the Phase 2 maintenance dose, then transitions to a monthly subscription:

StageVialWeekly dosesDose rangeDuration
115mg (4.95mg/ml)5 × weekly1 → 2 → 3 → 4 → 5mg5 weeks
230mg (9.90mg/ml)5 × weekly4 → 5 → 6 → 7 → 8mg5 weeks
332mg (32mg/ml)4 × weekly8mg fixedMonthly
Each titration vial is empty at dose 5 — designed as a one-month supply. The 32mg maintenance vial uses a 1.0ml fill: 30 clicks = 0.25ml = 8mg — same pen technique as every other compound. Vial reconstituted and empty within 4 weeks.

It depends on the compound and your dosing frequency. Here are the typical requirements — full detail is in the Protocols tab:

CompoundTypical cycleVials needed
GLP3-PlusStages 1+2 (10 weeks)1 × 15mg + 1 × 30mg, then 1 × 32mg/month
MOTS-c8–12 weeks daily~5 vials (8 wks) · ~7 vials (12 wks)
BPC-1574–6 weeks~3 vials once daily · ~5–6 twice daily (acute)
TB-5008–12 weeks loading~5 vials loading · 1 vial per 3 months maintenance
SS-318–12 weeks daily~8 vials daily · ~5 vials at 5×/week
GHK-Cu4–8 weeks1 vial per 4 weeks (3×/week at 15 clicks)
Ipamorelin8–12 weeks daily~4 vials per 8-week cycle
◆ The Compounds

MOTS-c is a 16-amino-acid peptide encoded directly in the mitochondrial genome. It activates AMPK — the master metabolic regulator — improving insulin sensitivity, metabolic flexibility, and exercise capacity. Research focus: metabolic recalibration, energy utilisation, longevity signalling. No completed human clinical trials to date — dosing is extrapolated from preclinical models.

BPC-157 is a 15-amino-acid peptide derived from a protective gastric juice protein. It promotes healing across multiple tissue types — gut wall repair, tendon and ligament regeneration, muscle recovery, and angiogenesis via VEGFR2 upregulation. Inject near the injury site where possible. For acute injury: twice daily. For maintenance or gut support: once daily.

TB-500 is a synthetic analogue of Thymosin Beta-4. It promotes actin polymerisation — enabling cell migration to injury sites — accelerating repair across muscle, tendon, ligament, skin, and cardiac tissue. Works systemically: injection site does not need to be near the injury. Often stacked with BPC-157 for comprehensive repair coverage.

SS-31 (Elamipretide) concentrates in the inner mitochondrial membrane, binding cardiolipin — critical to the electron transport chain. It stabilises crista architecture, reduces mitochondrial ROS, and restores ATP production efficiency. FDA granted accelerated approval in 2025 for Barth syndrome — the first approved mitochondrial membrane-targeted therapy.

GHK-Cu (Glycyl-L-Histidyl-L-Lysine Copper) activates over 4,000 human genes, the majority involved in tissue repair, collagen synthesis, anti-inflammatory regulation, and antioxidant defence. Plasma levels decline from ~200ng/ml at age 20 to under 80ng/ml by age 60. Note: at FRC concentration (16.50mg/ml) the full 30-click dose delivers 4.13mg — use 7 clicks (1mg) or 15 clicks (2mg) for introductory dosing.

Ipamorelin is a pentapeptide ghrelin mimetic that selectively stimulates natural growth hormone release without raising cortisol, ACTH, or prolactin — even at high doses. Half-life approximately 2 hours. Best taken 30–60 minutes before bed on an empty stomach to synergise with the natural nocturnal GH pulse. Standard dose: 30 clicks = 0.25ml = 165mcg.

NAD+ is the master coenzyme of cellular energy metabolism, central to over 500 enzymatic reactions and the essential cofactor for sirtuins (SIRT1–7) governing DNA repair, circadian rhythm, and cellular senescence. NAD+ levels decline by approximately 50% between ages 40 and 60.

GanodermaGOLD™ is built on MG-LZ8 — a proprietary Ganoderma sichuanense dual-phase extract that acts as a biological signal calibrator. Chronic inflammation and elevated cortisol create noise that disrupts immune communication. MG-LZ8 lowers that noise floor by supplying 5 of the 8 essential glyconutrients that build the glycoproteins immune cells use to signal each other.

Stacked with peptides, it ensures the signalling environment is clean enough for peptide instructions to land clearly. Particularly relevant with GLP3-Plus — reducing inflammatory baseline before starting a metabolic protocol improves response consistency significantly.

◆ Storage & Logistics

Unopened (lyophilised): refrigerate at 2–8°C. Keep away from direct light. Do not freeze.
After reconstitution: refrigerate at 2–8°C. Use within 4–6 weeks. Do not freeze the reconstituted solution — this degrades the peptide.
Allow vials to reach room temperature before opening to reduce condensation. Store the loaded pen tip-down in the fridge between doses.

Submit your selection using the enquiry form below. You will receive an invoice with EFT banking details and a reference number.

Delivery OptionAreaCost
Cape Town & Surrounds50km radiusR 150
National DeliveryAnywhere in SAR 200
CollectionStrand, Western CapeFree
◆ Compound Protocols
Stage 1 15mg Starter Vial
Conc4.95mg/ml
Fill3.03ml
Doses5 × weekly
Duration5 weeks
DoseWeekmgClicksml
1Week 11mg240.20ml
2Week 22mg480.40ml
3Week 33mg730.61ml
4Week 44mg970.81ml
5Week 55mg1211.01ml
◆ Recommended Stack
GLP3-Plus 15mg — weekly SC injection per schedule above
GanodermaGOLD™ Capsules — 1 daily · lowers inflammatory baseline before metabolic protocol
Autoimmune condition present? Replace capsules with Targeted Therapy Drops
Vial is empty at dose 5. Linear titration — each week increases by 1mg. GI side effects (nausea, delayed gastric emptying) are transient and diminish as the body adapts at each level.
Stage 2 30mg Full Protocol Vial
Conc9.90mg/ml
Fill3.03ml
Doses5 × weekly
Duration5 weeks
Begin immediately after completing the 15mg vial · Same weekly injection day
DoseWeekmgClicksml
1Week 64mg480.40ml
2Week 75mg610.51ml
3Week 86mg730.61ml
4Week 97mg850.71ml
5Week 108mg970.81ml
Vial is empty at dose 5. Ramp begins at 4mg (step-back from 5mg end of Stage 1 — allows body to recalibrate on new concentration). Ends at 8mg — Phase 2 trial maintenance dose.
Stage 3 32mg Maintenance Vial
Conc32mg/ml
Fill1.0ml
Doses4 × weekly
Duration4 weeks
Begin week 11 · Fixed dose · Monthly subscription vial
DoseSchedulemgClicksml
1–4Weekly8mg300.25ml
30 clicks = 0.25ml = 8mg — same pen technique as every other compound. Vial reconstituted and empty within 4 weeks. Monthly subscription cadence. Phase 2 trial data: 22.8% mean body weight loss at 8mg/week over 48 weeks (Retatrutide / LY3437943).
Protocol MOTS-c — Daily Titration
Vial20mg
Conc6.60mg/ml
Fill3.03ml
Doses12/vial
30 clicks = 0.25ml = 1.65mg · Daily SC · Before exercise or morning fasted
PhaseDaily DoseNotes
Weeks 1–2200mcg (4 clicks)Titrate up as tolerated
Weeks 3–4400mcg (7 clicks)Daily SC
Weeks 5–6600mcg (11 clicks)Daily SC
Weeks 7–8800mcg (15 clicks)Daily SC
Weeks 9+1,000mcg (30 clicks)Full dose = 1.65mg
Cycle8–12 weeks on · 2–4 weeks off
TimingBefore exercise or morning fasted for best AMPK response
Vials / cycle~5 vials per 8-week cycle at daily dosing (12 doses/vial). Titration weeks use fewer — budget 6–7 for a full 12-week cycle
No completed human clinical trials — dosing extrapolated from preclinical models. Stack with GanodermaGOLD™ Capsules to lower inflammatory baseline and improve metabolic signal clarity.
Protocol BPC-157 — Repair Protocol
Vial10mg
Conc3.30mg/ml
Fill3.03ml
Doses12/vial
30 clicks = 0.25ml = 0.83mg (825mcg) · SC near injury site where possible
PhaseDoseFrequency
Titration (Wks 1–2)200mcg (7 clicks)Daily SC
Build (Wks 3–4)400mcg (15 clicks)Daily SC
Maintenance600mcg (22 clicks)Once daily SC
Acute injury600mcg (22 clicks)Twice daily (AM + PM)
Cycle4–6 weeks on · 2 weeks off
TimingAny consistent time · No food restriction required
Vials / cycle~3 vials per 4-week cycle at once daily (12 doses/vial ÷ 7 days = ~12 days per vial). Acute twice-daily: ~5–6 vials per 4-week cycle
For acute injury: twice daily. For gut support or maintenance: once daily. Effects reported within days at this dose range. Rotate sites — abdomen, thighs, upper arms.
Protocol TB-500 — Loading & Maintenance
Vial10mg
Conc3.30mg/ml
Fill3.03ml
Doses12/vial
30 clicks = 0.25ml = 0.83mg (825mcg)
PhaseDoseFrequency
Loading (Wks 1–6)500–1,000mcg (18–36 clicks)2×/week SC
Maintenance500mcg (18 clicks)1×/week or 1×/fortnight
Cycle8–12 weeks on · 4 weeks off
Vials / cycle~5 vials per 8-week loading cycle (2×/week = ~8 doses/month ÷ 12 doses per vial). Maintenance: 1 vial per 3 months at 1×/week
TB-500 works systemically — injection site does not need to be near the injury. Stack with BPC-157 for comprehensive repair: BPC-157 addresses local tissue and gut, TB-500 drives systemic cell migration. WADA prohibited — not for competitive athletes.
Protocol SS-31 — Mitochondrial Support
Vial10mg
Conc4.44mg/ml
Fill2.25ml
Doses9/vial
30 clicks = 0.25ml = 1.11mg · Note: 2.25ml fill gives 9 doses (not 12)
Dose1.11mg SC daily — standard dose from Day 1
FrequencyDaily SC · 3–5×/week minimum
Cycle8–12 weeks on · 4 weeks off
TimingMorning preferred · Stack with MOTS-c for combined mitochondrial support
Vials / cycle~8 vials per 8-week cycle at daily dosing (9 doses/vial ÷ 7 days = ~9 days per vial). At 5×/week: ~5 vials per 8-week cycle
FDA granted accelerated approval (2025) for SS-31 (elamipretide / Forzinity) for Barth syndrome — first approved mitochondrial membrane-targeted therapy. Clinical trial doses 5–10mg/day — FRC supply at 1.11mg/dose is the introductory research range.
Protocol GHK-Cu — Tissue & Gene Regulation
Vial50mg
Conc16.50mg/ml
Fill3.03ml
Doses12/vial
30 clicks = 0.25ml = 4.13mg · High concentration — lower click counts for conservative dosing
ProtocolDoseFrequencyWeekly
Conservative7 clicks = 1mg5×/week SC~5mg
Standard15 clicks = 2mg5×/week SC~10mg
Alternative15 clicks = 2mg3×/week SC~6mg
Cycle4–8 weeks on · 2–4 weeks off
TimingAny consistent time · Rotate sites
Vials / cycle1 vial per 4-week cycle at standard 15-click dose (2mg) 3×/week — 12 doses covers ~4 weeks exactly. 5×/week: 1 vial per 2.5 weeks
Activates over 4,000 human genes. At FRC concentration (16.50mg/ml) the full 30-click dose delivers 4.13mg. For introductory dosing use 7 clicks (1mg) or 15 clicks (2mg) — both within literature range.
Protocol Ipamorelin — GH Secretagogue
Vial2mg
Conc0.66mg/ml
Fill3.03ml
Doses12/vial
30 clicks = 0.25ml = 165mcg · Empty stomach · 30–60 min before bed
PhaseDoseClicks
Weeks 1–2100mcg18 clicks
Weeks 3–4150mcg27 clicks
Weeks 5+165mcg30 clicks
Cycle8–12 weeks on · 2–4 weeks off
TimingBedtime · Empty stomach · Avoid food 2h before + 30min after
Vials / cycle~4 vials per 8-week cycle at daily dosing (12 doses/vial ÷ 7 days = ~12 days per vial)
Half-life ~2 hours. Raises no cortisol, ACTH or prolactin at effective doses. Bedtime dosing synergises with natural nocturnal GH pulse. Receptor desensitisation not observed in animal studies.
Tap a compound for research detail · Select to enquire
◆ 100% Natural · GanodermaGOLD™
◆ Research Compounds · Synthetic
No items selected
 
⭡ Selected for enquiry
Add items to your basket above
Estimated total
R 0
Prices exclude delivery
Subject to availability
◆ Submit Enquiry
Your name
Contact number
Email address
Research context / Notes
Sent directly via email · No data stored · Research use only